These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

973 related items for PubMed ID: 17289836

  • 1. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC.
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [Abstract] [Full Text] [Related]

  • 2. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
    Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC.
    Mol Cancer Ther; 2004 Jul; 3(7):803-12. PubMed ID: 15252141
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
    Omar HA, Arafa el-SA, Maghrabi IA, Weng JR.
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):464-71. PubMed ID: 24401154
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B.
    Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072
    [Abstract] [Full Text] [Related]

  • 5. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB.
    Mol Pharmacol; 2006 Jan 24; 69(1):195-206. PubMed ID: 16219905
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ, Jang JH, Noh HJ, Park EJ, Choi KS, Kwon TK.
    J Cell Biochem; 2010 Apr 01; 109(5):885-95. PubMed ID: 20127709
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 10. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
    Thanaketpaisarn O, Waiwut P, Sakurai H, Saiki I.
    Int J Oncol; 2011 Jul 01; 39(1):279-85. PubMed ID: 21537836
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y, Sarkar FH.
    Clin Cancer Res; 2002 Jul 01; 8(7):2369-77. PubMed ID: 12114442
    [Abstract] [Full Text] [Related]

  • 18. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
    Festa M, Petrella A, Alfano S, Parente L.
    Int J Cancer; 2009 Jun 01; 124(11):2728-36. PubMed ID: 19230027
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.
    Andrzejewski T, Deeb D, Gao X, Danyluk A, Arbab AS, Dulchavsky SA, Gautam SC.
    Oncol Res; 2008 Jun 01; 17(6):257-67. PubMed ID: 19192720
    [Abstract] [Full Text] [Related]

  • 20. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
    Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ.
    Mol Cancer Ther; 2006 Sep 01; 5(9):2251-60. PubMed ID: 16985059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.